書籍詳細

1. 慢性頭痛を知る (慢性頭痛の基礎知識)

P.11 掲載の参考文献

• 1) 慢性頭痛治療ガイドライン作成小委員会:慢性頭痛治療ガイドライン2002. 臨床神経 42:330-362, 2002

• 2) Headache Classification Subcommittee of the International Headache Society:The International Classification of Headache Disorders; 2nd Edition. Cephalalgia 24(suppl 1):1-160, 2004

P.12 掲載の参考文献

• 1) Silberstein SD et al:Overview, diagnosis, and classification of headache. Wolff's Headache and Other Head Pain, 7th ed., ed Silberstein SD et al, Oxford University Press, New York, 2001, pp6-26

P.19 掲載の参考文献

• 1) 慢性頭痛治療ガイドライン作成小委員会:慢性頭痛治療ガイドライン2002. 臨床神経 42:330-362, 2002

P.21 掲載の参考文献

• 1) 鈴木則宏:片頭痛の発生機序と新しい治療. 脳と神経 52:287-295, 2000

• 2) 濱田潤一:片頭痛-診断. 診断と治療 90:855-861, 2002
  Medical*Online

• 3) 竹島多賀夫, 中島健二:トリプタン系頭痛薬. 治療学 36:69-76, 2002

P.23 掲載の参考文献

• 1) 作田 学:緊張型頭痛の発生機序. 内科 81:630-633, 1998

• 2) 北川泰久:緊張型頭痛の病態. 診断と治療 86:837-844, 1998

• 3) 森松光紀:緊張型頭痛 診断基準と診断の実際. 日内会誌 90:630-635, 2001

P.25 掲載の参考文献

• 1) Ekbom K et al:Diagnosis, differential diagnosis and prognosis of cluster headache. The Headache, 2nd ed., ed Olsen J et al, Lippincott Williams & Wilkins, Philadelphia, 2000, pp725-729

• 2) 荒木信夫:片頭痛・群発頭痛の病態と発症機序. 医薬ジャーナル 36:3054-3060, 2000

• 3) 鈴木則宏:群発頭痛の治療. 医薬ジャーナル 36:3067-3071, 2000

P.27 掲載の参考文献

• 1) Mathew NT:Transformed migraine. Cephalalgia 13(Suppl 12):78-83, 1993

• 2) 竹島多賀夫:血管性頭痛と緊張型頭痛の一元論. 臨床医 22:2624-2627, 1996

• 3) 片山宗一:混合型頭痛の治療. 片頭痛エッセンス, ライフ・サイエンス, 東京, 2000, pp134-138

P.29 掲載の参考文献

• 1) Symonds C:Cough headache. Brain 79:557-568, 1956
  pubmed

• 2) 山根清美:労作性頭痛. 診断と治療 90:925-928, 2002
  Medical*Online

• 3) Lane JC et al:Exertional, cough and sexual headaches. Curr Treat Options in Neurology 4:375-381, 2002

P.32 掲載の参考文献

• 1) Silberstein SD et al:Classification of daily and near-daily headaches:Field trial of revised IHS criteria. Neurology 47:871-875, 1996
  pubmed

• 2) The International Classification of Headache Disorders 2nd Edition:The International Headache Society Official Homepage:http://www.i-h-s.org (Cephalalgia 24 Suppl 1, 2004)

• 3) 高瀬 靖:薬剤誘発性頭痛, 慢性連日性頭痛. ストレスと臨床 13:29-33, 2002
  Medical*Online

P.35 掲載の参考文献

• 1) The International Classification of Headache Disorders 2nd Edition:The International Headache Society Official Homepage:http://www.i-h-s.org (Cephalalgia 24 Suppl 1, 2004)

• 2) 高瀬 靖:薬剤誘発性頭痛, 慢性連日性頭痛. ストレスと臨床 13:29-33, 2002
  Medical*Online

P.37 掲載の参考文献

• 1) 北見公一:脳外科サイドからみた頭痛. 痛みと臨床 7:295-303, 2002

P.40 掲載の参考文献

• 1) 山田和男:身体表現性障害としての頭痛. ストレスと臨床 13:16-19, 2002
  Medical*Online

• 2) 北見公一ほか:脳神経外科領域における筋収縮性頭痛患者の心理背景. 心身医療 3:400-405, 1991

• 3) Jorge RE et al:Cluster headaches:association with anxiety disorders and memory deficits. Neurology 53:543-547, 1999
  pubmed

• 4) 北見公一:種々の治療に抵抗を示す慢性群発頭痛の1症例. 日本頭痛学会誌 27:44-45, 2000

2. 片頭痛の知識を深める

P.45 掲載の参考文献

• 1) Sakai F et al:Prevalence of migraine in Japan:a nationwide survey. Cephalalgia 17:15-22, 1997
  pubmed

• 2) Headache classification committee of the international headache society:Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl 7):9-96, 1988

P.51 掲載の参考文献

• 1) Headache classification committee of the international headache society:Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl.7):9-96, 1988

• 2) Headache classification subcommittee of the international headache society:The international classification of headache disorders 2nd edition. Cephalalgia 24(Suppl.1):8-151, 2004

• 3) Blau JN:Migraine prodromes separated from the aura. BMJ 281:658-660, 1980
  pubmed

P.57 掲載の参考文献

• 1) Lipton RB:Disability assessment as a basis for stratified care. Cephalalgia 18(S22):40-43, 1998

• 2) Stewart WF et al:An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53:988-994, 1999

• 3) Iigaya M et al:Reliability and Validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire. Headache 43:343-352, 2003
  pubmed

P.65 掲載の参考文献

• 1) Peroutka SJ:Serum glucose regulation and headache. Headache 42:303-308, 2002
  pubmed

• 2) Peikert A et al:Prophylaxis of migraine with oral magnesium:results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 16:257. 263, 1996

• 3) Schoenen J et al:Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 50:466-470, 1998
  pubmed

P.66 掲載の参考文献

• Russell MB et al:Migraine without aura and migraine with aura are inherited disorders. Cephalalgia 16(5):305-309, 1996
  pubmed

3. トリプタンについて知ろう

P.69 掲載の参考文献

• 1) 荒木信夫:片頭痛-病態解明と治療の進歩-. 日本医師会雑誌 128(11):1620-1624, 2002

• 2) 荒木信夫:片頭痛治療の新しい展開. Annual Review 神経 2003 (柳澤信夫ほか 編). 中外医学社, 東京, 2003, pp76-87

P.73 掲載の参考文献

• 1) 坂井文彦, 荒木信夫, 五十嵐久佳, 濱田潤一, 作田 学, 平田幸一, 鈴木則宏, 竹島多賀夫, 山根清美, 若田宣雄, 岩田 誠, 中島健二:日本神経学会治療ガイドライン慢性頭痛治療ガイドライン2002. 臨床神経学 42:330-362, 2002

P.75 掲載の参考文献

• 1) Humphrey PPA et al:GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol 94:1123-1132, 1988

• 2) Humphrey PPA et al:Preclinical studies on the anti-migraine drug, sumatriptan. Eur Neurol 31:282-290, 1991

• 3) Ferrari MD:Migraine. Lancet 351:1043-1051, 1998
  pubmed

P.77 掲載の参考文献

• 1) Moskowitz MA:The neurobiology of vascular head pain. Ann Neurol 16:157-168, 1984
  pubmed

• 2) Goadsby PJ et al:Migraine-Current understanding and treatment. N Engl J Med 346:257-270, 2002
  pubmed

• 3) 荒木信夫:片頭痛治療の新しい展開. Annual Review 神経 2003 (柳澤信夫ほか 編), 中外医学社, 東京, 2003, pp76-87

• 4) Goadsby PJ:The pharmacology of headache. Prog Neurobiol 62:509-525, 2000
  pubmed

P.83 掲載の参考文献

• 1) 片頭痛治療薬エレトリプタン (RELPAX). Medical Letter 日本語版 19:33, 2003

• 2) 坂井文彦ほか:SN-308 (Sumatriptan) 皮下注射液の第III相臨床試験-片頭痛患者を対象としたプラセボ注射液との二重盲検比較試験. 臨床医薬 16:283-300, 2000

• 3) イミグラン点鼻液20 新薬承認情報集

• 4) 坂井文彦ほか:コハク酸スマトリプタン錠 (GW102) の後期第II相臨床試験-片頭痛患者を対象としたプラセポとの二重盲検比較試験-. 臨床医薬 17:1163-1187, 2001

• 5) Rapoport A:The sumatriptan nasal spray:a review of clinical trials. Cephalalgia 21(suppl 1):13-15, 2001

• 6) Salonen R:The sumatriptan difference. Cephalalgia 21(suppl 1):18-20, 2001

• 7) GSK社内資料(2003年3月)

• 8) 平田幸一:トリプタンの妊婦における使用. 医学のあゆみ 204:479-482, 2003
  Medical*Online

• 9) Goadsby PJ:Serotonin 5-HT receptor agonists in migraine:Comparative pharmacology and its therapeutic implications. CNS Drugs 10:271-286, 1998

• 10) Fox AW:Comparative tolerability of oral 5-HT1B/1D agonists. Headache 40:521-527, 2000
  pubmed

P.85 掲載の参考文献

• 1) Martin GR:Pre-clinical pharmacology of zolmitriptan (Zomig(TM); formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine. Cephalalgia 17(Suppl 18):4-14, 1997

• 2) 濱田潤一:Triptanによる片頭痛の治療. 神経内科 54:217-225, 2001

• 3) Tepper S et al:Efficacy of oral zolmitriptan 2.5mg in mild, moderate, and severe migraine:Results of treating more than 20,000 attacks. Neurology 58(Suppl.3):A417, S55.008, 2002

• 4) Dowson AJ et al:Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine. Cephalalgia 22:101-106, 2002
  pubmed

P.88 掲載の参考文献

• 1) Napier C et al:Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H] eletriptan binding at human 5-HT1B and 5-HT1D receptors. Eur J Pharmacol 368:259-268, 1999
  pubmed

• 2) Maassen VanDenBrink A et al:Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. Neurology 55:1524-1530, 2000

• 3) Gupta P et al:The in Vivo pharmacological profile of eletriptan (UK-116, 044):a potent and novel 5-HT(1B/1D) receptor agonist. Eur J Pharmacol 398:73-81, 2000
  pubmed

• 4) Eletriptan Steering Committee in Japan:Efficacy and safety of eletriptan 20mg, 40mg and 80mg in Japanese migraineurs. Cephalalgia 22:416-423, 2002

• 5) Goadsby PJ et al:Eletriptan in acute migraine:a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology 54:156-163, 2000

• 6) Farkkila M et al:Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia 23:463-471, 2003
  pubmed

• 7) 清水俊彦:[片頭痛]片頭痛マネジメントの将来. 脳 21 6:79-86, 2003
  Medical*Online

P.91 掲載の参考文献

• 1) Longmore J et al:Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries:immunohistological demonstration of the involvement of 5-HT1B-receptors. Br J Clin Pharmacol 46:577-582, 1998
  pubmed

• 2) Ferro A et al:A comparison of the contractile effects of 5-hydroxytryptamine, sumatriptan and MK-4620n human coronary artery in vitro. Br J Clin Pharmacol 40:245-251, 1995

• 3) Longmore J et al:5-HT1D receptor agonists and human coronary artery reactivity in vitro:crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741, 519. Br J Clin Pharmacol 42:431-441, 1996
  pubmed

• 4) Longmore J et al:Comparison of the vasoconstrictor properties of the 5-HT1D-receptor agonists rizatriptan (MK-462) and sumatriptan in human isolated coronary artery:outcome of two independent studies using different experimental protocols. Funct Neurol 12:3-9, 1997
  pubmed

• 5) Williamson DJ et al:The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasadon. Eur J pharmacol 328:61-64, 1997
  pubmed

• 6) Goadsby PJ et al:Migraine-current understanding and treatment. N Engl J Med 346(4):257-270, 2002
  pubmed

• 7) 杏林製薬 申請資料

P.93 掲載の参考文献

• 1) Deleu D et al:Current and emerging second-generation triptans in acute migraine therapy:a comparative review. J Clin Pharmacol 40:687-700, 2000
  pubmed

• 2) Havanka H et al:Efficacy of naratriptan tablets in the acute treatment of migraine:a dose-ranging study. Naratriptan S2WB2004 Study Group. Clin Ther 22:970-980, 2000

• 3) Klassen A et al:Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group. Headache 37:640. 645, 1997

• 4) Mathew NT et al:Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group. Neurology 49:1485-1490, 1997

• 5) Gobel H et al:Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group. Clin Ther 22:981-989, 2000

• 6) Heywood J et al:Tolerability and efficacy of naratriptan tablets in the acute treatment of migraine attacks for 1 year. Naratriptan Long-Term Study Group. Cephalalgia 20:470-474, 2000
  pubmed

• 7) Tfelf-Hansen P et al:Triptans in migraine:a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60:1259-1287, 2000

• 8) Ferrari MD et al:Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment:a meta-analysis of 53 trials. Lancet 358:1668-1675, 2001
  pubmed

P.94 掲載の参考文献

• 清水俊彦ほか:片頭痛治療におけるスマトリプタン錠の医療経済学的検討. 診療と新薬 38:787-799, 2001

4. トリプタンを使いこなそう

P.97 掲載の参考文献

• 1) 慢性頭痛治療ガイドライン作成小委員会, 坂井文彦, 荒木信夫, 五十嵐久佳, 濱田 潤一, 作田 学, 平田幸一, 鈴木則宏, 竹島多賀夫, 山根清美, 若田宣雄, 岩田 誠, 中島 健二:日本神経学会治療ガイドライン慢性頭痛治療ガイドライン2002. 臨床神経 42:330-362, 2002

P.99 掲載の参考文献

• 1) 竹島多賀夫ほか:内科医のための神経内科 Minimum Essential-症候から:頭痛. 内科 91:599-606, 2003

P.101 掲載の参考文献

• 1) U.S. Headache Consortium Evidence-Based Headache Guidelines:BM Frishberg et al:Evidence-Based Guidelines in the Primary Care Setting:Neuroimaging in Patients with Nonacute Headache. http://www.aan.com/professionals/practice/pdfs/g10088.pdf

P.103 掲載の参考文献

• 1) Ferrari MD et al:Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:a meta-analysis of 53 trials. Lancet 358 (9294):1668-1675, 2001

• 2) 竹島多賀夫ほか:専門医に学ぶ頭痛診療のコツ:3. 慢性頭痛の治療. ガイドラインのポイント. 日本醫事新報 4089:8-16, 2002

• 3) 竹島多賀夫ほか:トリプタン系頭痛薬. 治療学 36:749-753, 2002
  Medical*Online

P.119 掲載の参考文献

• 1) 鈴木則宏:片頭痛, 急性期治療 (発作頓挫治療). 脳の科学 23:409-418, 2001

P.121 掲載の参考文献

• 1) 日本神経学会治療ガイドライン. Ad Hoc委員会:慢性頭痛ガイドライン2002, 臨床神経 42:330-362, 2002

P.123 掲載の参考文献

• Bell R et al:Comparative trial of three agents in the treatment of acute migraine. Ann Emerg Med 19:1079-1082, 1990

P.128 掲載の参考文献

• 日本神経学会治療ガイドライン Ad Hoc委員会:慢性頭痛治療ガイドライン2002. 臨床神経学 42:330-362, 2002

5. トリプタンの知識を深めよう

P.132 掲載の参考文献

• 各社添付文書

P.136 掲載の参考文献

• 1) Olesen C et al:Pregnancy outcome following prescription for sumatriptan. Headache 40:20-24, 2000
  pubmed

• 2) O'Quinn S et al:Pregnancy and perinatal outcomes in migraineurs using sumatriptan:a prospective study. Arch Gynecol Obstet 263:7-12, 1999

• 3) Fox AW et al:Evidence-based assessment of pregnancy outcome after sumatriptan exposure. Headache 42:8-15, 2002
  pubmed

• 4) 平田幸一:トリプタンの妊婦における使用. 医学のあゆみ 204:479-482, 2003
  Medical*Online

• 5) Silberstein SD et al:Wolffs Headache and other head pain, Seventh edition, Oxford university press, 2001, pp981-986

P.139 掲載の参考文献

• 1) Winner P et al:Classification of pediatric migraine:proposed revisions to the IHS criteria. Headache 35:407-410, 1995

• 2) 藤田光江:経口スマトリプタンの小児片頭痛における使用. 医学のあゆみ 204:475-478, 2003
  Medical*Online

• 3) Linder SL et al:Zolmitriptan provides effective migraine relief in adolescents. Int J Clin Pract 54:466-469, 2000
  pubmed

P.143 掲載の参考文献

• 1) Castillo J et al:Epidemiology of chronic daily headache in the general population. Headache 39:190-196, 1999
  pubmed

• 2) 五十嵐久佳ほか:緊張型頭痛の疫学調査. 日本頭痛学会誌 25:17-19, 1997

• 3) Silberstein SD et al:Classification of daily and near-daily headaches:Proposed revisions to the IHS criteria. Headache 34:1-7, 1994

P.145 掲載の参考文献

• 1) Headache Classification Committee of the International Headache Society:Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalalgia 8(Suppl7):54-56, 1988

P.149 掲載の参考文献

• 1) Klapper J et al:Triptans in the treatment of basilar migraine and migraine with prolonged aura. Headache 41(10):981-984, 2001
  pubmed

• 2) 竹島多賀夫ほか:特殊な片頭痛患者におけるトリプタン使用の是非-片麻痺性片頭痛, 脳底型片頭痛など. 医学のあゆみ 204:483-487, 2003

P.152 掲載の参考文献

• EBM漢方 (寺澤捷年ほか編), 医歯薬出版, 2003, pp223-229

6. 服薬指導のポイント

P.161 掲載の参考文献

• 1) 山根清美ほか:緊張型頭痛におけるめまいの臨床的検討. 日本頭痛学会誌 30:118-120, 2003